GlassScriptPhysician profile
Haider Ali
NPI 1063032761
$5,982.62
in general payments reported to CMS, 2019-2025
18 companies · $1,654 in 2025
The $1,654 reported for 2025 was more than what 78% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,329 · 2025: $1,654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $3,939 · Food and Beverage: $1,584 · Travel and Lodging: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $3,939.36 |
| Food and Beverage | $1,583.96 |
| Travel and Lodging | $459.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,939.28 | 2024-2025 | Proclaim, Eterna |
| Medtronic, INC. | $1,729.76 | 2024-2025 | Synchromedii, Intellis Adaptivestim |
| Spinal Simplicity, LLC | $316.52 | 2024-2025 | Ha Minuteman G3-R |
| Spr Therapeutics, INC | $230.44 | 2024-2025 | Sprint Pns System |
| Boston Scientific Corporation | $153.39 | 2025 | Wavewriter Alpha Prime 16 |
| Convatec INC. | $126.14 | 2025 | |
| Si-Bone, INC. | $85.49 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.24 | 2025 | Relistor |
| Globus Medical, INC. | $66.61 | 2025 | Senza |
| Biotronik Nro, INC. | $50.71 | 2025 | Prospera |
| Nalu Medical, INC. | $46.53 | 2025 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $44.31 | 2025 | Xtampza |
| Valinor Pharma, LLC | $35.33 | 2025 | Movantik |
| Tonix Medicines, INC. | $21.98 | 2025 | Tonmya |
| Ucb, INC. | $20.93 | 2025 | Bimzelx |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $15.86 | 2025 | Evoke |
| Lundbeck LLC | $15.09 | 2025 | Vyepti |
| Abbvie INC. | $15.01 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haider Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.